Oncology treatment is all about timing, primarily when recovery and fatality depend on when a specific treatment is initiated. Detection and determination of the biomarker level in lung cancer patients help in making the right decision to start a particular treatment. Communication between the laboratory who tests for the biomarker and the oncologist is critical. Delay in getting results due to data errors or mismatch in communication data may eventually decrease the chances of patient survival. MedTrix developed the PDL-1 Biomarker mobile application to help close this gap between the oncologist in one of the Asian regions and the specialist laboratory in the UK. The app offers a secure channel of communication between the two. The physician can book a patient biopsy from their hospital and receive the laboratory report directly in their account in the mobile app. When there is a data mismatch, the app helps speed up the correction by allowing the laboratory to connect with the physician via instant chat and get a resolution quickly. At the laboratory end, MedTrix created a seamless workflow process for managing data, records, and their organization profile on the platform. The laboratory can also manage users' database to give them the flexibility in adding value for the oncologist by easing the most significant pain point. Oncologists can now avoid report mismatch and have visibility on when they can expect to receive the results. The most exceptional value that this platform offers is oncologists' ability to take treatment decisions on time.
Experimental / Innovative
Black Chateau Enterprises